Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• Phenotypic diversity in genetic disorders remains poorly understood.
• UBE3A gene loss-of-function causes Angelman syndrome, a neurodevelopmental disorder.
• Mechanisms driving varied phenotypes in monogenic disorders require further elucidation.

Purpose of the Study:

• To develop a large-scale assay for characterizing the functional impact of UBE3A missense variants.
• To identify gain-of-function variants in UBE3A and assess their phenotypic consequences.
• To explore the regulatory role of specific residues within UBE3A.

Main Methods:

• Development of a high-throughput assay to determine functional valence (gain/loss-of-function) of UBE3A variants.
• In vivo studies using mouse models with specific UBE3A mutations (e.g., Q588E).
• Structure-function analysis of UBE3A and conserved regulatory sites.

Main Results:

• Identification of numerous gain-of-function UBE3A variants, including a hyperactivating Q588E mutation.
• Q588E mutation leads to increased UBE3A activity and aberrant early-life motor and communication deficits in mice.
• Phenotypes associated with hyperactivating UBE3A variants are distinct from Angelman syndrome.
• Q588 identified as a conserved regulatory site in UBE3A, relevant to neurodevelopmental disorders.

Conclusions:

• Excessive UBE3A activity is implicated in neurodevelopmental pathology.
• Functional variant analysis is crucial for distinguishing mechanistic subtypes within monogenic disorders.
• Hyperactivating UBE3A variants represent a distinct class of neurodevelopmental conditions.